Since the initial description of this protein in 2001, high levels of CDCP1 have been shown to be associated with a higher frequency of solid tumors in various models, including colon, prostate, pancreas, lung, renal and skin cancers [2,4–7]. Here, CDCP1 is linked to skin cancer.